#Amicus Therapeutics (FOLD)

Outperforming, favorite, and undervalued biotech firms

The Week in Review #28 The approval of revolutionary products created by biotech firms with solid scientific fundamentals, superior scientists and advanced technologies is what motivates us to pick fo...

P

Prohost Biotech

Sep 3, 2018

Motif Bio Has Good News. Amicus Therapeutics Has a Series of Good News

MOTIF BIO Antibiotic Motif Bio’s (MTFB ) antibiotic drug Iclaprim met the Phase 3 Revive-2 trial’s primary endpoints of non-inferiority against the current standard of care antibiotic, vancomycin in...

P

Prohost Biotech

Oct 5, 2017

1m

12

News & Comments

Amicus' Drug Failed! Why Investors Are Not Abandoning Ship

Amicus (FOLD) announced the failure of its topical wound-healing product SD-101 for patients with epidermolysis bullosa (EB). The drug failure was revealed when top-line results from the randomized, d...

P

Prohost Biotech

Sep 13, 2017

Results of the Round Table Picks

THE ROUND TABLE DISCUSSION THE RESULTS CLDX 90%; CMRX 70%; FOLD 60%; CCXI 50%; CUR 50%; IMMU 0%; CEMP 0%; ADHD 0% It was clear that the votes went to Celldex (CLDX) as a current investm...

P

Prohost Biotech

Sep 20, 2013

Closing in on Breast Cancer, Including HER2, ER&#43 and the Riskiest Triple Negative. Read Also About IMGN and News From Amicus (FOLD)

Closing in On Breast Cancer Closing in on breast cancers is a work in progress, which began years ago with the emergence of the targeted treatment Herceptin by Genentech/Roche for HER2 breast cancer...

P

Prohost Biotech

Feb 15, 2013

Has Illumina Accepted Roche's New Offer? Is Amicus's Technology Condemned as Some Say?

ROCHE/ILLUMINA DEAL? From Bloomberg, Thomas Muller wrote that Illumina gained in Frankfurt trading after Swiss newspaper L’Agefi said Roche Holding AG (ROG) may have agreed to buy IIllunina at a pric...

P

Prohost Biotech

Dec 20, 2012

Impacting News

Elan Chairman Provides Update on CEO Succession The Chairman of Elan (ELN) , Mr. Robert Ingram today provided an update on CEO succession . The update mentioned a prudent succession , explaining rea...

P

Prohost Biotech

Mar 2, 2012

Private Lessons #9

...

P

Prohost Biotech

Jun 22, 2011

1m

9